Skip to main content
. 2011 Jul 3;2011:757234. doi: 10.4061/2011/757234

Figure 1.

Figure 1

Additional evaluation based on breast CE-MRM findings and change in preoperative management. = MX/US: CE-MRM report in concordance with MX/US. > MX/US: CE-MRM detects more or larger lesions. B2: benign lesion; B3: lesion of uncertain malignant potential; B4: suspiciousnes of malignancy; B5: malignant (B5a: in situ carcinoma (DCIS) or B5b: invasive carcinoma) [14, 15]. N: number of patients.